Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Paclitaxel × Thoracic × Clear all

Status

Completed 249 Terminated 74 Recruiting 52 Active not recruiting 47 Unknown 42 Not yet recruiting 16 Withdrawn 15 Suspended 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1

Conditions

Prostatic Neoplasms 1 Lung Neoplasms 1

Interventions

tazemetostat 1 taletrectinib 1 rovalpituzumab tesirine 1 rociletinib 1 pegilodecakin 1 patritumab deruxtecan 1 osimertinib 1 lorlatinib 1 dabrafenib 1 ceritinib 1 capmatinib 1 brigatinib 1 alectinib 1 Suspensions 1 Powders 1 Paclitaxel 1 Nivolumab 1 BID protein, human 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03756311 2026-01-23

Expanded Access to NanoPac

NanOlogy, LLC

No longer available

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡